
Loading, please wait...

Loading, please wait...

Clinicians frequently encounter absence seizures in pediatric patients with idiopathic generalized epilepsies. Manual review of prolonged EEG records is often laborious and time-consuming. However, automated absence seizure detection offers a potential solution to improve laboratory workflow and clinical efficiency.
A recent study published in the Journal of Clinical Neurophysiology evaluated the Persyst software's performance in a pediatric cohort. Researchers analyzed eighty-one EEG records from sixty-nine patients to compare different software modules. They specifically focused on the seizure detection module and the spikeburst module, which identifies clusters of interictal epileptiform discharges.
The study results revealed that the seizure detection module achieved a sensitivity of 78%. In contrast, the spikeburst module showed varying results based on the duration settings. Specifically, a 1-second threshold reached a high sensitivity of 95% but resulted in 23 false positives every 24 hours. Increasing the threshold to 3 seconds reduced false positives to zero, yet the sensitivity dropped to 61%.
Consequently, the researchers determined that a 2-second spikeburst threshold represents the most feasible compromise. This setting offers a sensitivity of 77% with only one false positive per day. Moreover, both software modules performed exceptionally well for longer events, reaching 99% sensitivity for seizures exceeding nine seconds. Most false positives occurred due to interictal discharges rather than actual seizures.
Ultimately, these automated tools assist neurologists in triaging large volumes of EEG data. By using the 2-second spikeburst setting, clinicians can maintain high detection accuracy while minimizing the burden of reviewing false alarms. This efficiency gain is particularly valuable in high-volume pediatric neurology centers where rapid interpretation is essential for treatment adjustments.
The spikeburst module with a 2-second threshold duration is recommended. It provides a balanced performance with 77% sensitivity and a very low false positive rate of one per 24 hours.
The software is highly accurate for longer events. Both the seizure detection and spikeburst modules reach a 99% detection rate for absence seizures lasting more than 9 seconds.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.
References
Reus EEM et al. Performance of Automated Detection Software in Absence Seizures. J Clin Neurophysiol. 2026 Feb 19. doi: 10.1097/WNP.0000000000001242. PMID: 41712934.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study evaluates Persyst's automated detection software for absence seizures in pediatric EEGs, identifying the 2-second module as the most usable clinical...
6 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today